Search

Advanced filters
Published After
Published Before

Search Results

Found 225 items.

  • MATERIALS OF NOBEL SYMPOSIUM 175: PRECISION MEDICINE TRANSFORMS HEALTHCARE: A NEW TRAJECTORY FOR RESEARCH AND INNOVATION SEPTEMBER 20—22, 2023, STOCKHOLM, SWEDEN

    L. Kovalevska, E. Kashuba
    531-534
    12.12.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.531

  • PD-1 AND TIM-3 BLOCKING CANNOT ENHANCE APOPTOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS INDUCED BY PERIPHERAL BLOOD CD8+ T CELLS

    S. Jafarkhani, H. Hossein-Nataj, M. Eslami-Jouybari, M. Ghoreishi, H. Asgarian-Omran
    287-294
    09.03.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18975

  • EVOLUTION OF METFORMIN IN BREAST CANCER THERAPY IN LAST TWO DECADES: A REVIEW

    R. SARATHI, S. SARUMATHY, V.M. DURAI MAVALAVAN
    185-191
    19.12.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.03.185

  • THE STUDY OF PROGNOSTIC VALUE OF microRNAs (miR-10b AND -155) AND CDKN2A/P16INK4A IN ORAL SQUAMOUS CELL CARCINOMA

    О. Kravets, O. Burtyn, T. Borikun, O. Rossylna
    187-194
    11.10.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.187

  • ROLE OF RADIOPROTECTORS IN MINIMIZATION OF STOCHASTIC EFFECTS OF RADIATION INCIDENTS

    E.A. Domina, O.L. Kopylenko
    186-189
    26.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18530

  • Quinazoline compounds for antitumor treatment

    G.I. Solyanik
    3-6
    08.06.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12414

  • EXPRESSION OF GENES INVOLVED IN P53 PATHWAY REGULATION IN NEUROBLASTOMA: A SHORT REVIEW

    M. Inomistova, H. Klymniuk, N. Khranovska , S. Pavlyk, E. Shaida, O. Gorbach, O. Skachkova, D. Shymon
    266–271
    07.03.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18960

  • ASSOCIATION OF miRNA EXPRESSION PATTERN WITH OUTCOME OF LETROZOLE THERAPY IN BREAST CANCER PATIENTS

    O. Pridko, T. Borikun, O. Rossylna, A.V. Rusyn
    180-186
    11.10.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.180

  • Comparative evaluation of purine dysmetabolism in gastric and pulmonary adenocarcinomas

    Y.V. Dumanskiy, O.Y. Stoliarova, О.V. Syniachenko, R.F. Aliev, М.V. Iermolaeva, О.P. Sokrut
    220-223
    31.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-3.15068

  • KALERIIA PAVLIVNA GANINA: The Life Dedicated to Science and Mankind — On the Centennial Birthday

    Scientific Council
    77-78
    14.06.2026

  • IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY

    M. GOLOVENKO, I. VALIVODZ, A. REDER, V. LARIONOV
    51-59
    11.07.2025
    DOI: https://doi.org/10.15407/exp-oncology.2025.01.051

  • PROGNOSTIC VALUE OF THE DENSITY OF TUMOR-INFILTRATING LYMPHOCYTES AND ITS ASSOCIATION WITH CLINICAL-MORPHOLOGICAL FEATURES OF COLON ADENOCARCINOMAS

    B. SHKURUPII, L. ZAKHARTSEVA
    45-52
    31.05.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.01.045

  • IMPACT OF TUMOR MOLECULAR PHENOTYPE ON SURVIVAL OF PATIENTS WITH GASTRIC CANCER AFTER RADICAL SURGERY

    Yu.V. Dumanskyi, S.I. Kirkilevskyi, O.M. Sulaeva, V.O. Polyasnyi, A.O. Mashukov, L.A. Kovalevska, R.R. Yarema, M.A. Ogorchak
    324–326
    07.03.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18903

  • PHARMACOGENETIC MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA THERAPY

    L. Fishchuk, Z. Rossokha, N. Levkovych, O. Sheiko, O. Ievseienkova, L. Brisevac, O. Popova, V. Vershyhora, N. Gorovenko
    408-420
    05.03.2026
    DOI: https://doi.org/10.15407/exp-oncology.2025.04.408

  • GENETIC PREDICTORS OF TOXIC EFFECTS OF METHOTREXATE IN CANCER PATIENTS

    L. Fishchuk, O. Skavinska, O. Ievseienkova, Z. Rossokha, L. Sheiko
    399-408
    12.12.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.399

  • Peculiarities of epithelial-mesenchymal transition in endometrial carcinomas

    I. Nesina
    282-289
    26.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-4.16982

  • SEVERE DISEASE PROGRESSION OF POSTMOLAR GESTATIONAL NEOPLASM IN A VIETNAMESE YOUNG FEMALE PATIENT AFTER TREATMENT REFUSAL: INSIGHTS FROM A CASE REPORT AND LITERATURE REVIEW

    THANH NHAN VO, PHUC NHON NGUYEN
    154-164
    09.10.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.02.154

  • PRIMARY OVARIAN SYNOVIAL SARCOMA — A CASE REPORT

    A. Yordanov, K. Janeva, S. Mateva, Y. Kornovski, S. Kostov, S. Slavchev, Y. Ivanova, M. Nikolova
    334-336
    09.03.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.19072

  • Collision breast cancer and chronic lymphocytic leukemia/small lymphocytic lymphoma in a single lymph node (clinical case)

    L. Zakhartseva, M. Yanovytska
    274-276
    26.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16486

  • Clinical Case of Inferior Vena Cava Leiomyoma in a Patient with Thrombocytopenia

    Y. Dumanskiy, S. Reshetniak, D. Ievtushenko, D. Bondar, M. Mykhailyk
    73-76
    14.06.2026
    DOI: https://doi.org/10.15407/exp-oncology.2026.01.073

  • THE UBIQUITIN-PROTEASOME SYSTEM IN CANCER: MECHANISMS, TARGETS AND THERAPEUTIC POTENTIAL

    D. Nishchenko, S. Antonenko, D. Gurianov, M. Tesliuk, G. Telegeev
    395-407
    05.03.2026
    DOI: https://doi.org/10.15407/exp-oncology.2025.04.395

  • Digital Pathology as an Innovative Tool for Improving Cancer Diagnosis and Treatment

    T. ZADVORNYI
    289-294
    12.12.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.04.289

  • Drag reducing polymers attenuate adverse effects of ischemia-reperfusion upon resection of liver metastases modeled by MC38 mouse colon adenocarcinomama

    А.А. Burlaka, А.P. Burlaka, М.S. Кrotevych, Т.О. Rudiuk, V.E. Orel
    46-50
    01.06.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-1.14095

  • INTERPLAY OF LNCRNAS, METABOLIC CELL DEATH, AND IMMUNE MICROENVIRONMENT IN GENITOURINARY MALIGNANCIES

    V. Gordiiuk, L. Shevchenko, D. Todoryshyn, V. Kashuba, O. Mankovska
    143-155
    07.10.2025
    DOI: https://doi.org/10.15407/exp-oncology.2025.02.143

  • CLINICAL SIGNIFICANCE OF SALIVARY MIR-21, -155, AND -375 IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF ORAL CAVITY

    O. BURTYN, T. BORIKUN, O. ROSSYLNA, A. KOPCHAK, О. KRAVETS
    139-145
    09.10.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.02.139
201 - 225 of 225 items << < 4 5 6 7 8 9